CryoLife, Inc.
1655 Roberts Boulevard N.W.
Kennesaw
Georgia
30144
United States
Tel: 770-419-3355-or-800-438-8285
Fax: 770-426-0031
Website: http://www.cryolife.com/
Email: info@cryolife.com
343 articles about CryoLife, Inc.
-
CryoLife Announces Corporate Rebranding and Changes Name to Artivion
1/18/2022
CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced that it was renaming and rebranding itself to Artivion, Inc., effective immediately.
-
CryoLife to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum
11/9/2021
CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced that members of management will host one-on-one meetings at the upcoming Canaccord Genuity MedTech, Diagnostics, and Digital Health & Services Forum on Thursday, November 18, 2021.
-
CryoLife Reports Third Quarter 2021 Financial Results
11/4/2021
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today its financial results for the third quarter ended September 30, 2021.
-
CryoLife Announces Release Date and Teleconference Call Details for Third Quarter 2021 Financial Results
10/20/2021
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2021 financial results will be released on Thursday, November 4, 2021 after the market closes.
-
Anthony Semedo Joins CryoLife Board of Directors
9/22/2021
CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced the appointment of Anthony "Tony" Semedo to its Board of Directors effective October 1, 2021.
-
CryoLife to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
8/31/2021
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Morgan Stanley 19th Annual Global Healthcare Conference on Tuesday, September 14, 2021.
-
CryoLife to Participate in Upcoming Virtual Investor Conferences - Aug 02, 2021
8/2/2021
CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced that it will participate in two upcoming virtual investor conferences.
-
CryoLife Reports Second Quarter 2021 Financial Results
7/29/2021
CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced its financial results for the second quarter ended June 30, 2021.
-
CryoLife Announces Sale of PerClot to Baxter
7/29/2021
CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced that it has completed the sale of its PerClot product line to a subsidiary of Baxter International, Inc., for up to $60.8 million in cash.
-
CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results
7/15/2021
CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced that second quarter 2021 financial results will be released on Thursday, July 29, 2021 after the market closes.
-
CryoLife to Participate in the UBS Global Healthcare Virtual Conference
5/18/2021
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021 .
-
CryoLife Reports First Quarter 2021 Financial Results
4/29/2021
CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced its financial results for the first quarter ended March 31, 2021.
-
CryoLife Announces Release Date and Teleconference Call Details for First Quarter 2021 Financial Results
4/15/2021
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2021 financial results will be released on Thursday, April 29, 2021 after the market closes
-
CryoLife to Participate in 20th Annual Needham Virtual Healthcare Conference
4/7/2021
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 20th Annual Needham Virtual Healthcare Conference on Wednesday, April 14, 2021.
-
CryoLife to Participate in Oppenheimer 31st Annual Virtual Healthcare Conference
3/9/2021
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Oppenheimer 31 st Annual Virtual Healthcare conference on Tuesday, March 16 - 17, 2021.
-
CryoLife Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2020 Financial Results
1/28/2021
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full year 2020 financial results will be released on Thursday, February 11, 2021 after the market closes.
-
CryoLife Reports Third Quarter 2020 Financial Results
11/4/2020
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today its financial results for the third quarter ended September 30, 2020.
-
CryoLife Announces Release Date and Teleconference Call Details for 2020 Third Quarter Financial Results
10/21/2020
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 third quarter financial results will be released on Wednesday, November 4, 2020 after the market closes.
-
CryoLife to Present at the 18th Annual Morgan Stanley Global Healthcare Conference
9/8/2020
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 18th Annual Morgan Stanley Global Healthcare Conference
-
CryoLife Acquires Ascyrus Medical
9/2/2020
CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced that it has acquired Ascyrus Medical LLC.